BioSpace News Archive

Tularemia refers to a disease that generally attacks the lymph nodes, skin, eyes, and lungs. It is also called rabbit fever or deer fly fever. The leading cause of this disease is bacterium Francisella tularensis.

As previously announced, APTI’s scientists identified multiple compounds with high predicted affinity for the main SARS-CoV-2 protease by in silico modeling and synthetic efforts and preliminary testing were initiated.

ViaDerma, Inc., published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website reporting Convertible Notes Payable of $281,538.00 and a Convertible Line of Credit of $19,000.00.

Tarsier Pharma today announced it raised capital to execute a phase-3 clinical trial of its TRS01 program in the US and Europe .

Biocom California Appoints Bernard Parker as New Vice Chair of Diversity, Equity and Inclusion and Appoints Charles Dadswell as Chairman of Newly Formed Public Policy Advisory Committee

Researchers at Albert Einstein College of Medicine and the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH) have been awarded a five-year, $14.5 million grant from the National Institutes of Health (NIH)

OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that the Company will be present at the following investor events: H.C. Wainwright 23rd Annual Global Investment Conference - September 13 - 15, 2021

Siemens Healthineers announced today that its Enhanced Liver Fibrosis (ELF™) Test was granted marketing authorization under the De Novo review pathway.

A new study by scientists at Gladstone Institutes led by Senior Investigator Katerina Akassoglou, PhD, shows that many of the drugs currently in trials may not be sufficient to promote repair within these cells’ toxic environment and identifies a different treatment option that could improve the repair of myelin.

Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of Holly Schachner, M.D. a seasoned and accomplished industry veteran to its Board of Directors.